1.326 - 1.350 of 57.068
- Product
- Maturity
- Leverage (Omega)
- Sell
- Buy
- Nike Call 62,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 3,68x
- Analysis
- Nike Call 58,00 17 Jun 2027
- Goldman Sachs
- 17.06.27
- 3,19x
- Analysis
- Nike Call 64,00 17 Jun 2027
- Goldman Sachs
- 17.06.27
- 3,40x
- Analysis
- Nike Call 84,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 4,39x
- Analysis
- Nike Call 56,00 17 Jun 2027
- Goldman Sachs
- 17.06.27
- 3,14x
- Analysis
- Nike Call 68,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 3,91x
- Analysis
- Nike Call 66,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 3,82x
- Analysis
- Nike Call 80,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 4,22x
- Analysis
- Novo Nordisk Call 390,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 3,20x
- Analysis
- Nike Call 76,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 4,11x
- Analysis
- Nike Call 72,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 4,01x
- Analysis
- Nike Call 70,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 3,98x
- Analysis
- Nike Call 58,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 3,52x
- Analysis
- Nike Call 64,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 3,80x
- Analysis
- Moderna Call 34,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 1,76x
- Analysis
- Moderna Call 37,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 1,80x
- Analysis
- Moderna Call 25,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 1,59x
- Analysis
- Nike Call 66,00 17 Jun 2027
- Goldman Sachs
- 17.06.27
- 3,39x
- Analysis
- Moderna Call 26,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 1,61x
- Analysis
- Moderna Call 35,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 1,75x
- Analysis
- Moderna Call 30,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 1,68x
- Analysis
- Moderna Call 36,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 1,78x
- Analysis
- Moderna Call 27,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 1,64x
- Analysis
- Nike Call 86,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 4,32x
- Analysis
- Moderna Call 37,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 1,93x
- Analysis